You have 9 free searches left this month | for more free features.

City

Nijmegen (2)

Ghent (1)

Kopenhagen (1)

Munchen (1)

Newcastle upon Tyne (1)

Overall Status

Completed (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Khondrion BV (3)

Collaborator

Drug Research Unit Ghent, Belgium (1)

Julius Clinical, The Netherlands (1)

Radboud University Medical Center (1)

Intervention

kh176 (3)

placebo (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

kh176

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Mitochondrial Diseases, Mitochondrial Myopathies, Mitochondrial Encephalomyopathies Trial in Worldwide (KH176, Placebo)

Active, not recruiting

Mitochondrial Diseases
+4 more

KH176
Placebo

Kopenhagen, Denmark
+3 more

Mar 29, 2022

MELAS, LHON, Leigh Syndrome Trial in Ghent (KH176, )

Completed

Has Results

MELAS
+4 more

KH176
placebo

Ghent, Belgium

Drug Research Unit Ghent

Oct 15, 2021

Mitochondrial Diseases, Mitochondrial Myopathies, Mitochondrial Encephalomyopathies Trial in Nijmegen (KH176, )

Completed

Mitochondrial Diseases
+4 more

KH176
placebo

Nijmegen, Netherlands

Radboud University Medical Center

Feb 22, 2018